Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Researchers identify possible therapeutic target for depression and addiction - The Source - Washington University in St. Louis
Pathways and Receptors – Opioid Peptides
Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting” | Journal of Neuroscience
Development of κ opioid receptor antagonists. | Semantic Scholar
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry